Study to Evaluate Efficacy and Safety of Treatment with CNTO 136 in Subjects with Active Lupus Nephritis

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-020968-38

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to evaluate the efficacy and safety of CNTO 136 administered intravenously (IV) in subjects with active, International Society of Nephrology (ISN)/Renal Pathology Society (RPS) Class III and IV lupus nephritis (LN).


Critère d'inclusion

  • Active lupus nephritis